Valneva is a France-based biotechnology company that develops and commercializes vaccines for the treatment of infectious diseases...
Read moreValneva is a France-based biotechnology company that develops and commercializes vaccines for the treatment of infectious diseases...
Read moreAnnual Revenue
$555.2M
Valneva's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 4.6B. Over the last four quarters, Valneva's revenue has decreased by 83.3%. Specifically, in Q1 2022's revenue was $24.3M; in Q2 2022, it was $73.5M; in Q3 2022, it was $47.6M; in Q3 2022, Valneva's revenue was $145.4M.